Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex.

Target-specific intracellular delivery of small interfering RNA (siRNA) is regarded as one of the most important technologies for the development of siRNA therapeutics. In this work, a cysteamine modified gold nanoparticles (AuCM)/siRNA/polyethyleneimine (PEI)/hyaluronic acid (HA) complex was successfully developed using a layer-by-layer method for target-specific intracellular delivery of siRNA by HA receptor mediated endocytosis. Atomic force microscopic and zeta potential analyses confirmed the formation of a AuCM/siRNA/PEI/HA complex having a particle size of ca. 37.3 nm and a negative surface charge of ca. -12 mV. With a negligible cytotoxicity, AuCM/siRNA/PEI/HA complex showed an excellent target-specific gene silencing efficiency of ca. 70% in the presence of 50 vol % serum, which was statistically much higher than that of siRNA/Lipofectamine 2000 complex. In the competitive binding tests with free HA, dark-field bioimaging and inductively coupled plasma-atomic emission spectroscopy confirmed the target-specific intracellular delivery of AuCM/siRNA/PEI/HA complex to B16F1 cells with HA receptors. Moreover, the systemic delivery of AuCM/siRNA/PEI/HA complex using apolipoprotein B (ApoB) siRNA as a model drug resulted in a significantly reduced ApoB mRNA level in the liver tissue. Taken together, AuCM/siRNA/PEI/HA complex was thought to be developed as target-specific siRNA therapeutics for the systemic treatment of various liver diseases.

[1]  G. Decher,et al.  Functional core/shell nanoparticles via layer-by-layer assembly. investigation of the experimental parameters for controlling particle aggregation and for enhancing dispersion stability. , 2008, Langmuir.

[2]  D. Baltimore,et al.  Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Ellington,et al.  Directed evolution of gold nanoparticle delivery to cells. , 2010, Chemical communications.

[4]  V. Rotello,et al.  Polymer and biopolymer mediated self-assembly of gold nanoparticles. , 2008, Chemical Society reviews.

[5]  Jutaek Nam,et al.  pH-Induced aggregation of gold nanoparticles for photothermal cancer therapy. , 2009, Journal of the American Chemical Society.

[6]  Bin Zhou,et al.  Identification of the Hyaluronan Receptor for Endocytosis (HARE)* , 2000, The Journal of Biological Chemistry.

[7]  N. Nishiyama,et al.  Introduction of stearoyl moieties into a biocompatible cationic polyaspartamide derivative, PAsp(DET), with endosomal escaping function for enhanced siRNA-mediated gene knockdown. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[8]  T. Laurent,et al.  The structure and function of hyaluronan: An overview. , 1996, Immunology and cell biology.

[9]  T. Niidome,et al.  Preparation of primary amine-modified gold nanoparticles and their transfection ability into cultivated cells. , 2004, Chemical communications.

[10]  R. Langer,et al.  Gold, Poly(-amino ester) Nanoparticles for Small Interfering RNA Delivery , 2009 .

[11]  Min-young Lee,et al.  Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate. , 2010, Biomaterials.

[12]  I. Stamenkovic,et al.  CD44 is the principal cell surface receptor for hyaluronate , 1990, Cell.

[13]  E. Turley,et al.  HA receptors: Regulators of signalling to the cytoskeleton , 1996, Journal of cellular biochemistry.

[14]  J. Rossi,et al.  RNAi therapeutics: principles, prospects and challenges. , 2007, Advanced drug delivery reviews.

[15]  Brendan F Gilmore,et al.  Gene delivery using dimethyldidodecylammonium bromide-coated PLGA nanoparticles. , 2010, Biomaterials.

[16]  Matthias John,et al.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs , 2004, Nature.

[17]  Subashini Asokan,et al.  Effective gene silencing by multilayered siRNA-coated gold nanoparticles. , 2011, Small.

[18]  K. Yoshikawa,et al.  Hyaluronic acid and its derivative as a multi-functional gene expression enhancer: protection from non-specific interactions, adhesion to targeted cells, and transcriptional activation. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[19]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[20]  Jong-Hyuk Im,et al.  A simple method for hyaluronic acid quantification in culture broth , 2009 .

[21]  A. Hoffman,et al.  Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[22]  R. Pecora,et al.  Dynamic Light Scattering Measurement of Nanometer Particles in Liquids , 2000 .

[23]  M. Karkkainen,et al.  Preexisting Lymphatic Endothelium but not Endothelial Progenitor Cells Are Essential for Tumor Lymphangiogenesis and Lymphatic Metastasis , 2004, Cancer Research.

[24]  Mark A. Atwater,et al.  Extinction coefficient of gold nanoparticles with different sizes and different capping ligands. , 2007, Colloids and surfaces. B, Biointerfaces.

[25]  J. Hecker,et al.  Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells. , 2010, International journal of pharmaceutics.

[26]  Min Zhang,et al.  Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. , 2009, Small.

[27]  K. Yamamura,et al.  Ectopic expression of N-acetylglucosaminyltransferase III in transgenic hepatocytes disrupts apolipoprotein B secretion and induces aberrant cellular morphology with lipid storage. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Byung-Soo Kim,et al.  Effect of cross-linking reagents for hyaluronic acid hydrogel dermal fillers on tissue augmentation and regeneration. , 2010, Bioconjugate chemistry.

[29]  Petra Krystek,et al.  Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.

[30]  R. Schiffelers,et al.  Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. , 2004, Nucleic acids research.

[31]  Young Jik Kwon,et al.  Dual mode polyspermine with tunable degradability for plasmid DNA and siRNA delivery. , 2011, Biomaterials.

[32]  Jin-Zhi Du,et al.  Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery. , 2010, Small.

[33]  Rose Amal,et al.  Anti-fouling magnetic nanoparticles for siRNA delivery , 2010 .

[34]  S. Chae,et al.  Long acting hyaluronate--exendin 4 conjugate for the treatment of type 2 diabetes. , 2010, Biomaterials.

[35]  Chad A. Mirkin,et al.  Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation , 2006, Science.

[36]  Vincent M Rotello,et al.  Gold nanoparticles in delivery applications. , 2008, Advanced drug delivery reviews.

[37]  J. Borén,et al.  Transgenic Mice That Overexpress Mouse Apolipoprotein B , 1996, The Journal of Biological Chemistry.

[38]  K. Uhrich,et al.  Cytotoxicity of a unimolecular polymeric micelle and its degradation products. , 2001, Biomacromolecules.

[39]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[40]  Vincent M. Rotello,et al.  Self-assembly of nanoparticles into structured spherical and network aggregates , 2000, Nature.

[41]  A. Mikos,et al.  Poly(ethylenimine) and its role in gene delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[42]  Achim Goepferich,et al.  Layer-by-layer assembled gold nanoparticles for siRNA delivery. , 2009, Nano letters.

[43]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[44]  W. Hur,et al.  Bioimaging for targeted delivery of hyaluronic Acid derivatives to the livers in cirrhotic mice using quantum dots. , 2010, ACS nano.

[45]  P. White,et al.  BARRIERS TO SUCCESSFUL DELIVERY OF SHORT INTERFERING RNA AFTER SYSTEMIC ADMINISTRATION , 2008, Clinical and experimental pharmacology & physiology.